secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0000950170-24-110801
Event type: m_and_a
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 1.03, 2.04, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE files Chapter 11, enters stalking horse asset sale with Sonendo for $14M
--------------------------------------------------------------------------------

- Filed Chapter 11 on Oct 1, 2024; will operate as debtor-in-possession under Bankruptcy Court.
- Stalking horse APA with Sonendo: $14M cash plus assumed liabilities and Delaware litigation settlement.
- DIP financing commitment of at least $2.5M from SWK Funding LLC; $1.43M interim advance.
- Sale subject to court-supervised auction; higher bids may emerge.
- Securityholders likely receive no recovery; equity investment highly speculative.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000095017024110801/0000950170-24-110801-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000095017024110801/biol-20240930.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-110801

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer